IDEAYA Biosciences Inc.
23.41
0.67 (2.95%)
At close: Jan 15, 2025, 1:40 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -112.96M -58.66M -49.76M -34.49M -41.98M -34.35M -11.86M
Depreciation & Amortization 4.01M 2.10M 1.73M 1.38M 1.25M 886.00K 391.00K
Stock-Based Compensation 18.49M 11.63M 8.24M 3.61M 2.17M 950.00K 136.00K
Other Working Capital -16.04M -44.31M -23.54M 83.77M -89.00K 1.33M 1.31M
Other Non-Cash Items -11.55M -695.00K 1.83M 562.00K -467.00K 4.11M -2.43M
Deferred Income Tax n/a n/a n/a n/a n/a -873.00K -27.00K
Change in Working Capital -13.21M -41.55M -17.81M 84.41M -284.00K 1.65M 1.56M
Operating Cash Flow -115.22M -87.17M -55.78M 55.46M -39.31M -27.62M -12.22M
Capital Expenditures -2.37M -3.44M -2.64M -493.00K -1.35M -1.71M -1.76M
Acquisitions n/a 33.40M 67.02M -18.00K -8.00K n/a n/a
Purchase of Investments -595.98M -255.81M -315.00M -242.31M -88.00M -133.30M -13.47M
Sales Maturities Of Investments 439.89M 225.85M 247.97M 96.56M 91.62M 71.83M 6.30M
Other Investing Acitivies n/a -33.40M -67.02M 18.00K 8.00K -61.47M -7.17M
Investing Cash Flow -158.46M -33.40M -69.67M -146.24M 2.27M -63.18M -8.93M
Debt Repayment n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 52.95M 2.20M 2.20M 1.52M 289.00K 105.38M 17.49M
Financial Cash Flow 362.72M 97.17M 145.45M 128.75M 50.61M 105.38M 17.49M
Net Cash Flow 89.04M -23.41M 20.01M 37.97M 13.56M 14.58M -3.66M
Free Cash Flow -117.59M -90.62M -58.42M 54.97M -40.67M -29.33M -13.98M